Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.
about
Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomicsPopulation genomics reveal recent speciation and rapid evolutionary adaptation in polar bearsTesting for an unusual distribution of rare variants.A genome-wide association analysis for porcine serum lipid traits reveals the existence of age-specific genetic determinants.Assessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis.Disease risk factors identified through shared genetic architecture and electronic medical recordsAssociation of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals.Genetic determinants of plasma triglyceridesIntegrated role of two apoliprotein E polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population.Parent-of-Origin Effects of the APOB Gene on Adiposity in Young Adults.Association between apolipoprotein B gene polymorphisms and the risk of coronary heart disease (CHD): an update meta-analysis.The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.Polymorphisms in ApoB gene are associated with risk of myocardial infarction and serum ApoB levels in a Chinese population.Genetic variants influencing circulating lipid levels and risk of coronary artery disease.Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithmLipoproteins, cholesterol homeostasis and cardiac health.Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease.Lipoprotein(a): resurrected by genetics.Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks.Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.Natural selection shaped the rise and fall of passenger pigeon genomic diversity.Independent impacts of aging on mitochondrial DNA quantity and quality in humans.Plasma proteomics reveals coagulation, inflammation, and metabolic shifts in H-type hypertension patients with and without acute ischemic stroke.APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism.Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.Association between apolipoprotein B genetic polymorphism and the risk of calcific aortic stenosis in Chinese subjects, in Xinjiang, China.Apolipoprotein B and angiotensin-converting enzyme polymorphisms and aerobic interval training: randomized controlled trial in coronary artery disease patients.Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
P2860
Q26853114-1687B597-F39B-4539-BB41-A965F18BAE88Q28655936-36F5D032-3DFF-43A7-AB95-9AF6F4283FE5Q33847792-34098950-6B6F-414C-9347-DD191DA2833AQ34184693-326126B4-FB28-4AE3-A9EC-7AAE73F9EA13Q34230420-6155A230-6B37-4FE1-A0AC-6F8EEE8E8F1FQ34418291-1F11791D-9685-4641-A2A2-37977C04DC40Q34438809-F8DEE408-4371-47D3-AA7D-EFBBF9D93DE3Q34503333-4AD4950F-6F7A-4DE5-8AD8-CDFFF7B51B11Q35075040-63BF7569-E968-4CDB-A938-8B9DBEB754CFQ35801552-04C9FC03-FEC9-44E9-9869-5FC2B875FCB8Q35832524-ED59C216-EE5A-4973-B220-ED55E6F047B5Q36213916-5D0550DD-57A3-4AFF-89CD-EDF4C2568301Q36318087-C77A95AE-26A2-449B-9EED-3FB9641473B8Q37477713-C53CF587-6FBF-4582-B8E6-55D7852FD386Q37542168-5630CCF8-63BF-4A83-B794-7B158F3A63AFQ37544267-82440859-8130-4E7D-B02B-778F7FCB54A2Q37656313-270BBD7A-A439-4AEE-956E-4E965BDF544EQ38045424-960E6157-0373-4346-A6E4-1E6BE725ECF8Q42226136-D825AFCE-78DC-4100-AD2F-145DB6459359Q44776392-38A711CB-1D67-474C-8CDA-424C5067FBE1Q46251323-A3B07AFF-9216-4751-AAF8-23F249E7187CQ46272203-2D70D06D-B5A9-4710-AE4D-6C0E178A6ECEQ47159796-3309BE06-78D3-4D72-A44C-EB77A04D5011Q47547827-DD903B1E-CD7D-4F65-80E3-BD905D28C090Q48658510-23FE005E-5D33-4A2F-8AE9-8A8EC8556EF7Q52668852-241F5F92-7ED8-401B-A0A1-6954B2D9B1C1Q55300111-27E7907C-CB43-4899-B867-A90315FC79CEQ55413719-A92EA16B-3A06-4AD6-ACB1-BAB4065CA234
P2860
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apolipoprotein B levels, APOB ...... general population, a review.
@en
Apolipoprotein B levels, APOB ...... general population, a review.
@nl
type
label
Apolipoprotein B levels, APOB ...... general population, a review.
@en
Apolipoprotein B levels, APOB ...... general population, a review.
@nl
prefLabel
Apolipoprotein B levels, APOB ...... general population, a review.
@en
Apolipoprotein B levels, APOB ...... general population, a review.
@nl
P1433
P1476
Apolipoprotein B levels, APOB ...... general population, a review.
@en
P2093
Marianne Benn
P356
10.1016/J.ATHEROSCLEROSIS.2009.01.004
P577
2009-01-15T00:00:00Z